Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1229 (LINC01229)

Target
LINC01229
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC01229 (long intergenic non-protein coding RNA 1229) is a lincRNA gene that encodes a long non-coding RNA transcript with no protein-coding potential[1][7]. It is expressed in several tissue types and has been experimentally shown to negatively regulate the transcription of the MAF gene, an important transcription factor in kidney and metabolic pathways[3][5]. LINC01229 is implicated in the regulation of serum urate levels and inflammation, making it relevant to the pathogenesis of diseases such as gout and potentially kidney disorders[3][5]. Its biological function appears to center on the modulation of gene expression networks rather than serving as a receptor or enzyme. Currently, LINC01229 is not a known direct therapeutic target, nor are there approved drugs designed to modulate its activity[1][3][5].

Other names
TCONS_00024480LINC01229
02

Mechanism of action

Not applicable for drugs, as this is a non-coding RNA. Mechanistically, LINC01229 represses expression of the MAF gene, possibly through chromatin/transcriptional interactions.

03

Biological functions

Regulation of gene expression (notably, trans regulation of the MAF gene)Negative regulator of MAF transcription in kidney cellsImplicated in "cell development," lipid-related pathways (chylomicron assembly, high-density lipoprotein assembly, phospholipid efflux)Associated with inflammatory and immune functions ("interleukin β secretion," "T-cell differentiation," "interleukin 2 biosynthetic process")
04

Disease associations

Gout (regulation of genes involved in serum urate homeostasis)Inflammation (via modulation of cytokines such as interleukin β)Potential indirect relevance to kidney disease and metabolic disorders (via regulation of relevant pathways)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1229 (LINC01229).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1229 (LINC01229).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call